Overview
- 65 inspections across 64 sites are on record.
- 44 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-11-18.
At a glance
Inspections
65
Sites
64
Observations
44
Career since
Jun 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Sumitomo Pharma America, Inc. | 18 Nov 2021 | Human Drugs | |
| Sumitomo Pharma America, Inc. | 5 Nov 2021 | Human Drugs | |
| Andrea J. Bullock, MD | 6 Oct 2021 | Medical Devices & Rad Health | On file |
| Charles River Laboratories, Inc. | 22 Sep 2021 | Human Drugs | |
| Kenneth H. Mayer, M.D. | 26 Aug 2021 | Human Drugs |
Sites inspected
Sumitomo Pharma America, Inc.Marlborough, United States2 insp.
Andrea J. Bullock, MDBoston, United States1 insp.
Charles River Laboratories, Inc.Shrewsbury, United States1 insp.
Kenneth H. Mayer, M.D.Boston, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Jose A Torres3 shared
Darin S Wiegers2 shared
John L Zaccone2 shared
Matthew C Watson2 shared
Alicia A Dalley1 shared
Harlan J Howard1 shared
Erik W Koester1 shared
John P Mistler1 shared
Nabil Nakhoul1 shared
Kent A Conforti1 shared
Full investigator report
Get the verbatim findings behind Victoria M Daddeo's 44 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site